Palatin Technologies Inc
PTN
Company Profile
Business description
Palatin Technologies Inc is a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system. The product candidates are targeted, receptor-specific therapeutics for the treatment of diseases with significant unmet medical need and commercial potential.
Contact
4B Cedar Brook Drive
CranburyNJ08512
USAT: +1 609 495-2200
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
30 June 2026
Employees
30
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,841.90 | 8.30 | 0.09% |
| CAC 40 | 7,690.47 | 64.08 | -0.83% |
| DAX 40 | 23,806.47 | 127.66 | -0.53% |
| Dow JONES (US) | 44,828.53 | 344.11 | 0.77% |
| FTSE 100 | 8,800.42 | 22.78 | -0.26% |
| HKSE | 23,914.40 | 155.54 | -0.65% |
| NASDAQ | 20,601.10 | 207.97 | 1.02% |
| Nikkei 225 | 39,810.88 | 24.98 | 0.06% |
| NZX 50 Index | 12,766.60 | 62.12 | 0.49% |
| S&P 500 | 6,279.35 | 51.93 | 0.83% |
| S&P/ASX 200 | 8,603.00 | 7.20 | 0.08% |
| SSE Composite Index | 3,472.32 | 11.17 | 0.32% |